Related Experiment Video
Updated: May 23, 2026

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
Published on: February 25, 2022
Mortality and pituitary disease
Paul M Stewart1, Mark Sherlock
1Department of Endocrinology, The Medical School, College of Medical and Dental Sciences Edgbaston, University of Birmingham, United Kingdom. p.m.stewart@bham.ac.uk
Insights
Patients with pituitary tumors face higher mortality, mainly from vascular issues. Controlling hormone excess, like cortisol or growth hormone (GH), and managing cardiovascular risks can normalize mortality, but some risk may remain post-treatment.
Area of Science:
- Endocrinology
- Oncology
- Cardiovascular Medicine
Background:
- Pituitary tumors are associated with increased mortality.
- Vascular disease is a primary cause of death in these patients.
- Hormonal imbalances from pituitary tumors significantly impact patient outcomes.
Purpose of the Study:
- To analyze mortality data in patients with pituitary tumors.
- To identify key factors influencing mortality rates.
- To assess the impact of hormonal control and risk factor management on patient survival.
Main Methods:
- Review of outcome data from large patient series.
- Analysis of mortality causes, focusing on vascular disease.
- Evaluation of the effects of managing cortisol and growth hormone (GH) hypersecretion.
Main Results:
- Confirmed increased mortality in pituitary tumor patients.
- Identified vascular disease as the predominant cause of death.
- Demonstrated that controlling cortisol and GH hypersecretion, alongside cardiovascular risk reduction, normalizes mortality rates.
- Observed persistent excess mortality even in successfully treated patients.
Conclusions:
- Effective management of hormonal hypersecretion and cardiovascular risk factors is crucial for improving survival in Cushing's disease and acromegaly.
- While treatment can normalize mortality, a residual risk of excess mortality may persist.
- Further research may be needed to address the long-term residual risks in "cured" patients.
Abstract:
Outcome data from large series confirm increased mortality of patients with pituitary tumours, predominantly due to vascular disease. Control of cortisol secretion and growth hormone (GH) hypersecretion (together with cardiovascular risk factor reduction) is key in the normalisation of mortality rates in patients with Cushing's disease and acromegaly, respectively, though some excess mortality may persist even in "cured" patients.
Related Concept Videos
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Hypothyroidism II: Pathophysiology
Graves Disease II: Pathophysiology
Hyperthyroidism II: Pathophysiology
Cushing Syndrome II: Pathophysiology
The Pituitary Gland

